A detailed history of Cwm, LLC transactions in Geron Corp stock. As of the latest transaction made, Cwm, LLC holds 749 shares of GERN stock, worth $3,160. This represents 0.0% of its overall portfolio holdings.

Number of Shares
749
Previous 224 234.38%
Holding current value
$3,160
Previous $1,000 200.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$4.17 - $4.99 $2,189 - $2,619
525 Added 234.38%
749 $3,000
Q2 2024

Jul 09, 2024

BUY
$3.1 - $5.09 $613 - $1,007
198 Added 761.54%
224 $1,000
Q1 2024

Apr 05, 2024

BUY
$1.75 - $3.44 $45 - $89
26 New
26 $0

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.59B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.